Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Skin & Soft Tissues Diseases specialty page provides skin & soft tissue-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


FDA Approves Premixed Vancomycin Injection
The FDA has approved room temperature stable, premixed vancomycin injections, which will be available in ready-to-use bags.
Oral Antibiotics Non-Inferior to IV Antibiotics for Orthopedic Infections in OVIVA Trial
Although IV antibiotics have been the standard of care for bone and joint infections, a new study finds that oral antibiotics were non-inferior.
FDA Issues Complete Response Letter for Iclaprim
The FDA has granted issued a Complete Response Letter to Motif Bio regarding the New Drug Approval for iclaprim.
Inappropriate Antimicrobial Use in the Emergency Department for Skin and Soft Tissue Infections
Studies have shown high rates of inappropriate antibiotic prescribing and opportunity for improvement when it comes to ABSSSIs.
Herpes Zoster Complication in Vaccinated 19-Year-Old Linked to Corticosteroid Treatment
In a report detailing the hospitalization of a college student with complications from a herpes zoster infection, investigators say a corticosteroid prescription likely impaired the patient’s antiviral immune response.
Antimicrobial Susceptibility Tests and Surveillance Program Accompany Omadacycline Launch
Paratek Pharmaceuticals has announced the launch of omadacycline, including 3 antimicrobial susceptibility tests and a surveillance program.
Initial Safety Surveillance on Shingrix Consistent With Clinical Trial Data
Post-licensure safety data on recombinant zoster vaccine (Shingrix) is consistent with pre-licensure clinical trial data, although the CDC cautions that the immunization is still in the “early uptake period.”
'Victorian-Era' Diseases on the Rise in the UK, but Why?
Hospital visits for so-called “Victorian-era” diseases are on the rise in the United Kingdom, and experts there believe public health budget cuts may be behind the upswing.
Big advances in treatment can